Your browser doesn't support javascript.
loading
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.
Zhang, Xiaotian; Liang, Han; Li, Ziyu; Xue, Yingwei; Wang, Yanong; Zhou, Zhiwei; Yu, Jiren; Bu, Zhaode; Chen, Lin; Du, Yian; Wang, Xinbao; Wu, Aiwen; Li, Guoli; Su, Xiangqian; Xiao, Gang; Cui, Ming; Wu, Dan; Chen, Li; Wu, Xiaojiang; Zhou, Yanbing; Zhang, Lianhai; Dang, Chengxue; He, Yulong; Zhang, Zhongtao; Sun, Yihong; Li, Yong; Chen, Huanqiu; Bai, Yuxian; Qi, Changsong; Yu, Peiwu; Zhu, Guanbao; Suo, Jian; Jia, Baoqing; Li, Leping; Huang, Changming; Li, Fei; Ye, Yingjiang; Xu, Huimian; Wang, Xin; Yuan, Yannan; E, Jian-Yu; Ying, Xiangji; Yao, Chen; Shen, Lin; Ji, Jiafu.
Afiliação
  • Zhang X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • Liang H; Department of Gastric Surgery, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
  • Li Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • Xue Y; Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Wang Y; Department of Gastric Surgery, Fudan University Shanghai Cancer Centre, Shanghai, China.
  • Zhou Z; Department of Gastric Surgery, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China.
  • Yu J; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Bu Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • Chen L; Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Du Y; Department of Gastric Surgery and Department of Hepatopancreatobiliary Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
  • Wang X; Department of Gastric Surgery and Department of Hepatopancreatobiliary Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
  • Wu A; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • Li G; Department of General surgery, Nanjing Jinling Hospital, Nanjing, China.
  • Su X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • Xiao G; Department of General Surgery, Beijing Hospital, Beijing, China.
  • Cui M; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • Wu D; Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Chen L; Department of General Surgery, Chinese PLA General Hospital, Beijing, China.
  • Wu X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • Zhou Y; Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Zhang L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • Dang C; Department of Oncology Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • He Y; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Zhang Z; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Sun Y; Department of General Surgery, Zhongshan Hospital, Fudan University, Guangzhou, China.
  • Li Y; Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Chen H; Department of General Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • Bai Y; Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Qi C; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • Yu P; Department of General Surgery, The First Hospital Affiliated to Army Medical University, Chongqing, China.
  • Zhu G; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Suo J; Department of Gastrointestinal Surgery, The First Hospital of Jilin University, Changchun, China.
  • Jia B; Department of General Surgery, Chinese PLA General Hospital, Beijing, China.
  • Li L; Department of Gastrointestinal Surgery, Shandong Provincial Hospital, Jinan, China.
  • Huang C; Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Li F; Department of General Surgery, Xuanwu Hospital Capital Medical University, Beijing, China.
  • Ye Y; Department of General Surgery, Peking University People's Hospital, Beijing, China.
  • Xu H; Department of Gastrointestinal Oncology Surgery, The First Hospital of China Medical University, Shenyang, China.
  • Wang X; Department of General Surgery, Peking University First Hospital, Beijing, China.
  • Yuan Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • E JY; Wilmer Eye Institute, Johns Hopkins University School of Medicine and Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Ying X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • Yao C; Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China.
  • Shen L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China. Electronic address: shenlin@bjmu.edu.cn.
  • Ji J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China. Electronic address: jijiafu@hsc.pku.edu.cn.
Lancet Oncol ; 22(8): 1081-1092, 2021 08.
Article em En | MEDLINE | ID: mdl-34252374
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Junção Esofagogástrica Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Junção Esofagogástrica Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China